UP

Pfizer-BioNTech is 70% effective against Delta variant

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
Pfizer-BioNTech is 70% effective against Delta variant

Pfizer-BioNTech jabs are 70% effective against the highly contagious Delta variant of COVID-19, according to a study conducted in Israel.

Axar.az reports citing foreign media that the results of Hebrew University's research on the vaccine's efficacy were published by the Israeli Public Broadcasting Corporation (KAN) on Sunday.

The new finding is compared to the 95% rate of effectiveness of the vaccine against earlier virus strains.

Delta variant, which was first detected in India, is said to be responsible for more than 90% of new COVID cases in Israel over the past two weeks.

Since December 2019, the pandemic has claimed over 3.97 million lives in 192 countries and regions, with some 183.74 million cases reported worldwide, according to US-based Johns Hopkins University.

Date
2021.07.05 / 17:41
Author
Axar.az
See also

Red meat increases stroke risk in older adults

Avoid alcohol in autumn to protect your immunity

Uzbek, Kazakh doctors perform robotic surgery in Tashkent

WHO warns of dangerous India-made cough syrups

Azerbaijan receives Sanofi influenza vaccines

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla